Literature DB >> 24954795

Acylation in trypanosomatids: an essential process and potential drug target.

Amanda M Goldston1, Aabha I Sharma1, Kimberly S Paul2, David M Engman3.   

Abstract

Fatty acylation--the addition of fatty acid moieties such as myristate and palmitate to proteins--is essential for the survival, growth, and infectivity of the trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, and Leishmania. Myristoylation and palmitoylation are critical for parasite growth, targeting and localization, and the intrinsic function of some proteins. The trypanosomatids possess a single N-myristoyltransferase (NMT) and multiple palmitoyl acyltransferases, and these enzymes and their protein targets are only now being characterized. Global inhibition of either process leads to cell death in trypanosomatids, and genetic ablation of NMT compromises virulence. Moreover, NMT inhibitors effectively cure T. brucei infection in rodents. Thus, protein acylation represents an attractive target for the development of new trypanocidal drugs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  myristoylation; palmitoylation; trafficking; virulence

Mesh:

Substances:

Year:  2014        PMID: 24954795      PMCID: PMC4190163          DOI: 10.1016/j.pt.2014.05.003

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  114 in total

1.  Protein S-myristoylation in Leishmania revealed with a heterologous reporter.

Authors:  D A Armah; K Mensa-Wilmot
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

2.  Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei.

Authors:  G A Cross
Journal:  Parasitology       Date:  1975-12       Impact factor: 3.234

3.  Membrane targeting of the small myristoylated protein 2 (SMP-2) in Leishmania major.

Authors:  Joanne Heng; Eleanor C Saunders; Paul R Gooley; Malcolm J McConville; Thomas Naderer; Dedreia Tull
Journal:  Mol Biochem Parasitol       Date:  2013-05-30       Impact factor: 1.759

Review 4.  What does S-palmitoylation do to membrane proteins?

Authors:  Sanja Blaskovic; Mathieu Blanc; F Gisou van der Goot
Journal:  FEBS J       Date:  2013-04-18       Impact factor: 5.542

Review 5.  Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.

Authors:  J A Sikorski; B Devadas; M E Zupec; S K Freeman; D L Brown; H F Lu; S Nagarajan; P P Mehta; A C Wade; N S Kishore; M L Bryant; D P Getman; C A McWherter; J I Gordon
Journal:  Biopolymers       Date:  1997       Impact factor: 2.505

6.  N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.

Authors:  Julie A Frearson; Stephen Brand; Stuart P McElroy; Laura A T Cleghorn; Ondrej Smid; Laste Stojanovski; Helen P Price; M Lucia S Guther; Leah S Torrie; David A Robinson; Irene Hallyburton; Chidochangu P Mpamhanga; James A Brannigan; Anthony J Wilkinson; Michael Hodgkinson; Raymond Hui; Wei Qiu; Olawale G Raimi; Daan M F van Aalten; Ruth Brenk; Ian H Gilbert; Kevin D Read; Alan H Fairlamb; Michael A J Ferguson; Deborah F Smith; Paul G Wyatt
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

Review 7.  Membrane targeting of lipid modified signal transduction proteins.

Authors:  Marilyn D Resh
Journal:  Subcell Biochem       Date:  2004

8.  Myristate exchange on the Trypanosoma brucei variant surface glycoprotein.

Authors:  L U Buxbaum; K G Milne; K A Werbovetz; P T Englund
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

9.  Glycosyl-sn-1,2-dimyristylphosphatidylinositol is the membrane anchor for Trypanosoma equiperdum and T. (Nannomonas) congolense variant surface glycoproteins.

Authors:  G S Lamont; J A Fox; G A Cross
Journal:  Mol Biochem Parasitol       Date:  1987-06       Impact factor: 1.759

10.  Trypanosoma brucei metacaspase 4 is a pseudopeptidase and a virulence factor.

Authors:  William R Proto; Esther Castanys-Munoz; Alana Black; Laurence Tetley; Catherine X Moss; Luiz Juliano; Graham H Coombs; Jeremy C Mottram
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

View more
  16 in total

Review 1.  All about that fat: Lipid modification of proteins in Cryptococcus neoformans.

Authors:  Felipe H Santiago-Tirado; Tamara L Doering
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 2.  Dynamic protein S-palmitoylation mediates parasite life cycle progression and diverse mechanisms of virulence.

Authors:  Robert W B Brown; Aabha I Sharma; David M Engman
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-02-20       Impact factor: 8.250

Review 3.  The physiology of protein S-acylation.

Authors:  Luke H Chamberlain; Michael J Shipston
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic Outcome.

Authors:  Felipe H Santiago-Tirado; Tao Peng; Meng Yang; Howard C Hang; Tamara L Doering
Journal:  PLoS Pathog       Date:  2015-05-13       Impact factor: 6.823

5.  N-terminal region of the catalytic domain of human N-myristoyltransferase 1 acts as an inhibitory module.

Authors:  Sujeet Kumar; Rajendra K Sharma
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

6.  AID-ing Signaling in Toxoplasma gondii.

Authors:  Kami Kim
Journal:  MBio       Date:  2017-07-25       Impact factor: 7.867

7.  Subcellular localisation of FLAG tagged enzymes of the dynamic protein S-palmitoylation cycle of Trypanosoma cruzi epimastigotes.

Authors:  Cassiano Martin Batista; Felipe Saad; Stephane Pini Costa Ceccoti; Iriane Eger; Maurilio José Soares
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-05-28       Impact factor: 2.743

8.  Treatment of Trypanosoma cruzi with 2-bromopalmitate alters morphology, endocytosis, differentiation and infectivity.

Authors:  Cassiano Martin Batista; Rafael Luis Kessler; Iriane Eger; Maurilio José Soares
Journal:  BMC Cell Biol       Date:  2018-08-31       Impact factor: 4.241

9.  Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.

Authors:  Linda J Herrera; Stephen Brand; Andres Santos; Lilian L Nohara; Justin Harrison; Neil R Norcross; Stephen Thompson; Victoria Smith; Carolina Lema; Armando Varela-Ramirez; Ian H Gilbert; Igor C Almeida; Rosa A Maldonado
Journal:  PLoS Negl Trop Dis       Date:  2016-04-29

10.  Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei.

Authors:  Megan H Wright; Daniel Paape; Helen P Price; Deborah F Smith; Edward W Tate
Journal:  ACS Infect Dis       Date:  2016-04-29       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.